Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Zuo-Jiong Gong"'
Autor:
Jin Guo, Chun-Xia Shi, Qing-Qi Zhang, Wei Deng, Lu-Yi Zhang, Qian Chen, Dan-Mei Zhang, Zuo-Jiong Gong
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 15 (2022)
Over the past two decades, non-alcoholic fatty liver disease (NAFLD) has become a leading burden of hepatocellular carcinoma and liver transplantation. Although the exact pathogenesis of NAFLD has not been fully elucidated, recent hypotheses placed m
Externí odkaz:
https://doaj.org/article/eb7d2098348046b7af07fb9d71179145
Autor:
Chun-xia Shi, Yao Wang, Fang-zhou Jiao, Qian Chen, Pan Cao, Mao-hua Pei, Lu-yi Zhang, Jin Guo, Wei Deng, Lu-wen Wang, Zuo-jiong Gong
Publikováno v:
Frontiers in Physiology, Vol 12 (2021)
Chronic liver inflammation is a complex pathological process under different stress conditions, and the roles of stellate cells and macrophages in chronic liver inflammation have been widely reported. Moderate liver inflammation can protect the liver
Externí odkaz:
https://doaj.org/article/a1e45202477c4454a0d47474b5e9de67
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 10 (2020)
Background: Histones could be released from the nucleus when stimulated. Increasing evidence has shown that extracellular histones are associated with a variety of inflammation and diseases. Nucleotide binding oligomerzation domain 2 (NOD2) belongs t
Externí odkaz:
https://doaj.org/article/da502193eb494dcca6f4003b11b137ed
Autor:
Wen-bin Zhang, Fan Yang, Yao Wang, Fang-zhou Jiao, Hai-yue Zhang, Lu-wen Wang, Zuo-jiong Gong
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 117, Iss , Pp - (2019)
Background: Histone deacetylase 6 (HDAC6) has been considered as an important regulator in the development of inflammatory diseases. However, the mechanism of HDAC6 in regulating inflammatory responses has not been fully determined. In the present st
Externí odkaz:
https://doaj.org/article/f5dca0fc7b794592a77b775c14f37c72
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Background: ACY-1215 is a well-known selective histone deacetylase 6 (HDAC6) inhibitor, and it has been considered as a potential therapeutic drug in inflammatory diseases, including acute liver failure (ALF). However, little is known about the impac
Externí odkaz:
https://doaj.org/article/07133fb4f9d4444c83cf676907c7abb9
Publikováno v:
Mediators of Inflammation, Vol 2018 (2018)
The purpose of this study was to investigate the protective mechanism of HDAC2 inhibitor CAY10683 on intestinal mucosal barrier in acute liver failure (ALF). In order to establish ALF-induced intestinal epithelial barrier disruption models, D-galacto
Externí odkaz:
https://doaj.org/article/a1ad6b0d3987404fa4e523735de690a4
Publikováno v:
International Journal of Molecular Sciences, Vol 14, Iss 6, Pp 11224-11237 (2013)
Cisplatin is one of the most widely used chemical drugs for anticancer treatment. Recent studies have focused on the ability of cisplatin to retain the high mobility group box 1 (HMGB1) protein in cisplatin-DNA adducts, thereby preventing its release
Externí odkaz:
https://doaj.org/article/62cdf4f03cf44527ba36c0fe5fd49f23
Publikováno v:
International Journal of Molecular Sciences, Vol 11, Iss 9, Pp 3501-3512 (2010)
To investigate whether the JAK-STAT (Janus kinase-signal transducers and activators of transcription) pathway participates in the regulation of APOBEC3G (Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G) gene transcription and to s
Externí odkaz:
https://doaj.org/article/94ff9e0fe1ec425595a70497ce494ede
Publikováno v:
World Journal of Gastroenterology. 28:1798-1813
Publikováno v:
Hepatobiliary & Pancreatic Diseases International.